首页>
外国专利>
Use of the IL-1Beta binding antibody canakinumab for treating or alleviating symptoms of pulmonary sarcoidosis
Use of the IL-1Beta binding antibody canakinumab for treating or alleviating symptoms of pulmonary sarcoidosis
展开▼
机译:IL-1Beta结合抗体canakinumab在治疗或缓解肺结节病症状中的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
#$%^&*AU2020207771A120200806.pdf#####ll:terwovenNRPortblDCCSXD20443449 I.docx-16072020 ABSTRACT The present invention relates to a method for treating or alleviating the symptoms of pulmonary sarcoidosis in a subject, comprising administering about 25 mg to about 300 mg of canakinumab.
展开▼